Debate stirs over whether Apple should have disclosed more about Steve Jobs’ health

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts.

Apple CEO Steve Jobs. Credit: Paul Sakuma / AP.

Should Apple have said more?

Some legal scholars and investors say the Cupertino, Calif., company may have run afoul of securities regulations by not disclosing more about the severity of Steve Jobs’ medical condition.

The debate heated up after Steve Jobs’ transplant surgeon issued a statement Wednesday that the Apple chief executive was ‘the sickest man on the waiting list’ for a donor liver.

Here’s one expert’s view, from an article in today’s Times:

‘If they tried to lessen the disclosure and make it misleading by omission, that’s just as bad as telling something that flat isn’t true,’ said Jeffrey C. Soza, a securities lawyer at Glaser, Weil, Fink, Jacobs, Howard & Shapiro in Los Angeles.

-- Alex Pham